Ceribell Inc. accused Natus Medical Inc. and two of its units of infringing six patents related to its rapid electroencephalogram (EEG) monitoring system.
Ceribell pioneered a wearable EEG system that allows for rapid detection of seizures and other neurological conditions, filling an unmet need in acute care settings, it said in the complaint filed Monday in the US District Court for the District of Delaware. Ceribell said its patented system was launched in 2018 and has been widely adopted, with over 550 hospitals now using it. The complaint alleges that Natus—along with Excel-Tech Ltd. and Natus Neurology Inc.—copied Ceribell’s patented ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.